1. Gomaa EZ. Human gut microbiota/
microbiome in health and diseases: a
review. Antonie Van Leeuwenhoek.
2020;113(12):2019–40.
2. Çakırlar FK. Microbiota and
Metabolic Syndrome. Metabolic
Syndrome: A Comprehensive Update
with New Insights: Bentham Science
Publishers; 2025. p. 295–327.
3. de Almeida JIS. Generation and largescale expansion of highly functional
hpsc-derived hepatocytes for cellular
therapies and bioengineered livers: the
unknown role of human microbiome:
Universidad de Zaragoza; 2022.
4. Parizadeh M, Arrieta M-C. The
global human gut microbiome:
genes, lifestyles, and diet.
Trends in Molecular Medicine.
2023;29(10):789–801.
5. Portincasa P, Bonfrate L, Vacca M,
et al. Gut microbiota and short chain
fatty acids: implications in glucose
homeostasis. International journal of
molecular sciences. 2022;23(3):1105.
6. Ahamad R, Parveen S. Gut Microbiota
and Nutrient Enrichment: Mechanism
and Production of Vitamins.
Probiotics: CRC Press; 2024. p. 56–75.
7. Wiertsema SP, van Bergenhenegouwen
J, Garssen J, et al. The interplay
between the gut microbiome and
the immune system in the context of
infectious diseases throughout life
and the role of nutrition in optimizing
treatment strategies. Nutrients.
2021;13(3):886.
8. Khan I, Bai Y, Zha L, et al.
Mechanism of the gut microbiota
colonization resistance and enteric
pathogen infection. Frontiers in
Cellular and Infection Microbiology.
2021;11:716299.
9. Kim B, Song A, Son A, et al.
Gut microbiota and epigenetic
choreography: Implications for
human health: A review. Medicine.
2024;103(29):e39051.
10. Xi Y, Xu P. Global colorectal cancer
burden in 2020 and projections
to 2040. Translational oncology.
2021;14(10):101174.
11. Klimeck L, Heisser T, Hoffmeister
M, et al. Colorectal cancer: A health and economic problem. Best practice
& research clinical gastroenterology.
2023;66:101839.
12. Hossain MS, Karuniawati H, Jairoun
AA, et al. Colorectal cancer: a
review of carcinogenesis, global
epidemiology, current challenges,
risk factors, preventive and treatment
strategies. Cancers. 2022;14(7):1732.
13. Fan X, Jin Y, Chen G, et al. Gut
microbiota dysbiosis drives the
development of colorectal cancer.
Digestion. 2021;102(4):508–15.
14. Hrncir T. Gut microbiota dysbiosis:
triggers, consequences, diagnostic
and therapeutic options. MDPI; 2022.
p. 578.
15. Jandhyala SM, Talukdar R,
Subramanyam C, et al. Role of
the normal gut microbiota. World
journal of gastroenterology: WJG.
2015;21(29):8787.
16. Hossain KS, Amarasena S,
Mayengbam S. B vitamins and their
roles in gut health. Microorganisms.
2022;10(6):1168.
17. Tarracchini C, Lordan C, Milani C,
et al. Vitamin biosynthesis in the
gut: interplay between mammalian
host and its resident microbiota.
Microbiology and Molecular Biology
Reviews. 2025;89(2):e00184–23.
18. Role of the Gut Microbiome in
Colorectal Cancer: 서울대학교
대학원; 2025.
19. Joo JE, Chu YL, Georgeson P, et
al. Intratumoral presence of the
genotoxic gut bacteria pks+ E.
coli, Enterotoxigenic Bacteroides
fragilis, and Fusobacterium
nucleatum and their association
with clinicopathological and
molecular features of colorectal
cancer. British Journal of Cancer.
2024;130(5):728–40.
20. Kamel F, Eltarhoni K, Nisar P, et
al. Colorectal cancer diagnosis: the
obstacles we face in determining
a non-invasive test and current
advances in biomarker detection.
Cancers. 2022;14(8):1889.
21. Li S, Liu J, Zheng X, et al.
Tumorigenic bacteria in colorectal
cancer: mechanisms and treatments.
Cancer biology & medicine.
2022;19(2):147–62.
22. Ionescu VA, Diaconu CC, Gheorghe
G, et al. Gut Microbiota and Colorectal
Cancer: A Balance Between Risk and
Protection. International Journal of
Molecular Sciences. 2025;26(8):3733.
23. Gasaly N, Hermoso MA, Gotteland
M. Butyrate and the fine-tuning of
colonic homeostasis: implication
for inflammatory bowel diseases.
International journal of molecular
sciences. 2021;22(6):3061.
24. Carson TL, Byrd DA, Smith KS,
et al. A case–control study of
the association between the gut
microbiota and colorectal cancer:
exploring the roles of diet, stress, and
race. Gut Pathogens. 2024;16(1):13.
25. Nagata N, Nishijima S, Kojima Y,
et al. Metagenomic identification
of microbial signatures predicting
pancreatic cancer from a multinational
st udy. G a st roe nt e rolog y.
2022;163(1):222–38.
26. Lee JB, Kim K-A, Cho HY, et al.
Association between Fusobacterium
nucleatum and patient prognosis in
metastatic colon cancer. Scientific
reports. 2021;11(1):20263.
27. Ye C, Liu X, Liu Z, et al. Fusobacterium
nucleatum in tumors: from
tumorigenesis to tumor metastasis and
tumor resistance. Cancer biology &
therapy. 2024;25(1):2306676.
28. Saraiva MR, Rosa I, Claro I. Earlyonset colorectal cancer: A review of
current knowledge. World journal of
gastroenterology. 2023;29(8):1289.
29. Beniwal SS, Lamo P, Kaushik A,
et al. Current status and emerging
trends in colorectal cancer screening
and diagnostics. Biosensors.
2023;13(10):926.
30. Zhang H, Shi Y, Lin C, et al.
Overcoming cancer risk in
inflammatory bowel disease: new
insights into preventive strategies and
pathogenesis mechanisms including
interactions of immune cells,
cancer signaling pathways, and gut
microbiota. Frontiers in immunology.
2024;14:1338918.
31. Burgos-Molina AM, Téllez Santana T,
Redondo M, et al. The crucial role of
inflammation and the immune system
in colorectal cancer carcinogenesis:
a comprehensive perspective.
International Journal of Molecular
Sciences. 2024;25(11):6188.
32. Sun H, Zhai Q, Liu J, et al. Interplay
between the gut microbiota, its
metabolites and carcinogens.
Clinical and Translational Oncology.
2025:1–14.
33. Vinelli V, Biscotti P, Martini D, et
al. Effects of dietary fibers on shortchain fatty acids and gut microbiota
composition in healthy adults:
a systematic review. Nutrients.
2022;14(13):2559.
34. Salvi PS, Cowles RA. Butyrate and
the intestinal epithelium: modulation
of proliferation and inflammation
in homeostasis and disease. Cells.
2021;10(7):1775.
35. Mederle AL, Semenescu A, Drăghici
GA, et al. Sodium Butyrate:
A Multifaceted Modulator in
Colorectal Cancer Therapy. Medicina.
2025;61(1):136.
36. Mohamed Elfadil O, Mundi MS,
Abdelmagid MG, et al. Butyrate: more
than a short chain fatty acid. Current
nutrition reports. 2023;12(2):255–62.
37. Schmitt M, Greten FR. The
inflammatory pathogenesis of
colorectal cancer. Nature Reviews
Immunology. 2021;21(10):653–67.
38. Gieryńska M, Szulc-Dąbrowska
L, Struzik J, et al. Integrity of the
intestinal barrier: the involvement
of epithelial cells and microbiota—a
mutual relationship. Animals.
2022;12(2):145.
39. Di Vincenzo F, Del Gaudio A,
Petito V, et al. Gut microbiota,
intestinal permeability, and systemic
inflammation: a narrative review.
Internal and emergency medicine.
2024;19(2):275–93.
40. Kaur H, Ali SA. Probiotics and gut
microbiota: Mechanistic insights into
gut immune homeostasis through
TLR pathway regulation. Food &
Function. 2022;13(14):7423–47.
41. Candelli M, Franza L, Pignataro
G, et al. Interaction between
lipopolysaccharide and gut microbiota
in inflammatory bowel diseases.
International journal of molecular
sciences. 2021;22(12):6242.
42. Sadati S, Khalaji A, Bonyad A, et
al. NF-κB and apoptosis: colorectal
cancer progression and novel
strategies for treatment. European
Journal of Medical Research.
2025;30(1):616.
43. Zhao H, Wu L, Yan G, et al.
Inflammation and tumor progression:
signaling pathways and targeted
intervention. Signal transduction and
targeted therapy. 2021;6(1):263.
44. Augustine T, Kumar M, Al Khodor
S, et al. Microbial dysbiosis tunes
the immune response towards
allergic disease outcomes. Clinical
Reviews in Allergy & Immunology.
2023;65(1):43–71.
45. Cremonesi E, Governa V, Garzon
JFG, et al. Gut microbiota modulate T
cell trafficking into human colorectal
cancer. Gut. 2018;67(11):1984–94.
46. Aghamajidi A, Maleki Vareki S.
The effect of the gut microbiota on
systemic and anti-tumor immunity and
response to systemic therapy against
cancer. Cancers. 2022;14(15):3563.
47. Pinco P, Facciotti F. Unconventional
T Cells’ Role in Cancer: Unlocking
Their Hidden Potential to Guide
Tumor Immunity and Therapy. Cells.
2025;14(10):720.
48. Li Y, Jin L, Chen T. The effects
of secretory IgA in the mucosal
immune system. BioMed research
international. 2020;2020(1):2032057.49. Abokor AA, McDaniel GH, Golonka
RM, et al. Immunoglobulin A, an
active liaison for host-microbiota
homeostasis. Microorganisms.
2021;9(10):2117.
50. Botía-Sánchez M, Alarcón-Riquelme
ME, Galicia G. B cells and microbiota
in autoimmunity. International
Journal of Molecular Sciences.
2021;22(9):4846.
51. Ge Y, Wang X, Guo Y, et al.
Gut microbiota influence tumor
development and Alter interactions
with the human immune system.
Journal of Experimental & Clinical
Cancer Research. 2021;40(1):42.
52. Kiousi DE, Kouroutzidou AZ,
Neanidis K, et al. The role of
the gut microbiome in cancer
immunotherapy: current knowledge
and future directions. Cancers.
2023;15(7):2101.
53. Li X, Zhang S, Guo G, et al. Gut
microbiome in modulating immune
checkpoint inhibitors. EBioMedicine.
2022;82.
54. Fong W, Li Q, Yu J. Gut microbiota
modulation: a novel strategy
for prevention and treatment of
colorectal cancer. Oncogene.
2020;39(26):4925–43.
55. Gupta V, Garg R. Probiotics. Indian
journal of medical microbiology.
2009;27(3):202–9.
56. Parichat P, Pongsak R. Probiotics:
Sources, selection and health benefits.
Res J Biotechnol. 2023;18:5.
57. Barone M, Tavella T, Rampelli S,
et al. Host microbiomes in tumor
precision medicine: how far are
we? Current Medicinal Chemistry.
2022;29(18):3202–30.
58. Mazziotta C, Tognon M, Martini F, et
al. Probiotics mechanism of action on
immune cells and beneficial effects on
human health. Cells. 2023;12(1):184.
59. Ye Z, Liang L, Xu Y, et al. Probiotics
influence gut microbiota and tumor
immune microenvironment to enhance
anti-tumor efficacy of doxorubicin.
Probiotics and Antimicrobial Proteins.
2024;16(2):606–22.
60. Yeşilyurt N, Yılmaz B, Ağagündüz
D, et al. Involvement of probiotics
and postbiotics in the immune
system modulation. Biologics.
2021;1(2):89–110.
61. Naeem H, Hassan HU, Shahbaz M, et
al. Role of probiotics against human
cancers, inflammatory diseases,
and other complex malignancies.
Journal of Food Biochemistry.
2024;2024(1):6632209.
62. Gong D, Adomako-Bonsu AG, Wang
M, et al. Three specific gut bacteria
in the occurrence and development of
colorectal cancer: a concerted effort.
PeerJ. 2023;11:e15777.
63. Wong CC, Yu J. Gut microbiota in
colorectal cancer development and
therapy. Nature reviews Clinical
oncology. 2023;20(7):429–52.
64. Han S, Lu Y, Xie J, et al. Probiotic
gastrointestinal transit and
colonization after oral administration:
a long journey. Frontiers in cellular
and infection microbiology.
2021;11:609722.
65. Thoda C, Touraki M. Molecular
Mechanisms of Probiotic Action
Against Gastrointestinal Cancers.
International Journal of Molecular
Sciences. 2025;26(16):7857.
66. Peng F, Li S, Wang L, et al. Combination
of Hdac Inhibitor Sodium Butyrate
and Immunotherapy in Glioma:
Regulation of Immunologically Hot
and Cold Tumors Via Gut Microbiota
and Metabolites. Available at SSRN
4942877.
67. George J, Ghosh AR. Conjugated
Linoleic Acid in Cancer
Therapy. Current Drug Delivery.
2025;22(4):450–64.
68. Kazmierczak-Siedlecka K, Roviello
G, Catalano M, et al. Gut microbiota
modulation in the context of immunerelated aspects of Lactobacillus
spp. and Bifidobacterium spp. in
gastrointestinal cancers. Nutrients.
2021;13(8):2674.
69. Dikeocha IJ, Al-Kabsi AM, Eid EE,
et al. Probiotics supplementation
in patients with colorectal cancer:
a systematic review of randomized
controlled trials. Nutrition Reviews.
2022;80(1):22–49.
70. Maftei N-M, Raileanu CR, Balta
AA, et al. The potential impact of
probiotics on human health: an update
on their health-promoting properties.
Microorganisms. 2024;12(2):234.
71. Wolter M, Grant ET, Boudaud M, et
al. Leveraging diet to engineer the
gut microbiome. Nature reviews
Gastroenterology & hepatology.
2021;18(12):885–902.
72. Fassarella M, Blaak EE, Penders J,
et al. Gut microbiome stability and
resilience: elucidating the response
to perturbations in order to modulate
gut health. Gut. 2021;70(3):595–605.
73. Khannous-Lleiffe O, Willis JR, Saus
E, et al. Microbiome profiling from
fecal immunochemical test reveals
microbial signatures with potential for
colorectal cancer screening. Cancers.
2022;15(1):120.
74. Budu O, Banciu C, Pinzaru I, et al.
A combination of two probiotics,
Lactobacillus sporogenes and
Clostridium butyricum, inhibits
Colon Cancer Development: an
in Vitro Study. Microorganisms.
2022;10(9):1692.
75. Meroni G, Panelli S, Zuccotti G, et al.
Probiotics as therapeutic tools against
pathogenic biofilms: have we found
the perfect weapon? Microbiology
Research. 2021;12(4):916–37.
76. Yang Z, Zhang S, Ying L, et al. The
effect of probiotics supplementation
on cancer-treatment complications:
A critical umbrella review of
interventional meta-analyses.
Critical Reviews in Food Science
and Nutrition. 2025;65(19):3702–27.
77. Purushothaman S, Meola M, Egli
A. Combination of whole genome
sequencing and metagenomics
for microbiological diagnostics.
International journal of molecular
sciences. 2022;23(17):9834.
78. Shukla V, Singh S, Verma S,et al.
Targeting the microbiome to improve
human health with the approach
of personalized medicine: Latest
aspects and current updates. Clinical
Nutrition ESPEN. 2024;63:813–20.
79. Singh TP, Natraj BH. Next-generation
probiotics: a promising approach
towards designing personalized
medicine. Critical Reviews in
Microbiology. 2021;47(4):479–98.
)